Ophthalmology Innovation Summit

November 14, 2013

New Orleans, Sheraton

The Biosyntrx CEO, Ellen Troyer, and President, Spencer Thornton, MD will attend this 5th annual conference that unites clinical, technology and business leaders to address key issues impacting the ophthalmic field.  Innovators / entrepreneurs, clinicians, venture capitalists, senior R&D and executives from private and public companies will be attending this meeting.